SLXN (STOCKS)
Silexion Therapeutics Corp Ordinary Shares
$0.429800
-0.024300 (-5.35%)
Prev close: $0.454100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ilan Hadar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $0.48M
- Employees
- 14
- P/E (TTM)
- —
- P/B (TTM)
- 0.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-8.50 | $-13.16 | +4.6580 | +35.40% |
|
Dec 2025 (Q4)
|
$-14.00 | $-11.42 | -2.5760 | -22.55% |
|
Sep 2025 (Q3)
|
$-28.80 | $-34.68 | +5.8800 | +16.96% |
|
Jun 2025 (Q2)
|
$-43.20 | $-36.72 | -6.4800 | -17.65% |
Financial Statements
| Assets | $4.60M |
| Current Assets | $4.07M |
| Prepaid Expenses | $1.53M |
| Other Current Assets | $2.54M |
| Noncurrent Assets | $537.00K |
| Fixed Assets | $23.00K |
| Other Non-current Assets | $514.00K |
| Liabilities | $4.31M |
| Current Liabilities | $4.06M |
| Wages | $560.00K |
| Other Current Liabilities | $3.50M |
| Noncurrent Liabilities | $251.00K |
| Equity | $291.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $291.00K |
| Liabilities And Equity | $4.60M |